In the current study, we reported that autophagy was markedly triggered by talazoparib in CML cells, which was confirmed by the accumulation of autophagosomes, decrease of SQSTM1 and up-regulation of LC3-II. The gene discussed is SQSTM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.